case_images: PMC10990642_01
case_images: (a) 18F-FDG PET/CT: surface rendering (SR) of the skull (upper row) and corresponding fused axial PET/CT of the zygomatic region (lower row) before filler implant. (b) 18F-FDG PET/CT acquired during follow-up and after filler injection: SR of the skull (upper row) and fused axial PET/CT of the zygomatic region: no abnormal uptake, as a biomarker of inflammation, is evident with respect to the previous scan.
case_images: CRIONM2024-5559093.001.jpg
case_images: PMC10990642_01_CRIONM2024-5559093.001.jpg
case_images: fig1
case_images: No abnormal uptake is evident with respect to the previous PET-CT scan (Figure 1).